Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
NGNE
#2511
Neurogene, Inc. Common Stock
23.490
0
+21.87%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+21.87%
Variazione Mensile
+18.04%
Variazione di 6 mesi
-20.16%
Variazione Annuale
-20.16%
Chiusura Precedente
19.275
0
Open
23.490
0
Bid
Ask
Low
23.490
0
High
23.490
0
Volume
39
Mercati
Mercato Azionario Statunitense
Salute
NGNE
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
8.47 M
8.5 M
8.56 M
12.85 M
14.93 M
—
Valuation ratios
Enterprise value
—
—
—
107.18 M
204.7 M
652.93 M
Price to earnings ratio
—
—
—
-0.14
-5.34
-15.71
Price to sales ratio
—
—
—
—
434.14
—
Price to cash flow ratio
—
—
—
0.15
5.69
17.16
Price to book ratio
—
—
—
0.04
1.29
2.12
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.37
0.5
0.16
0.22
0.28
Return on equity %
0.17
0.42
0.61
0.2
0.24
0.3
Return on invested capital %
2 641.78
1 426.14
1 258.74
2 485.3
1 635.68
—
Gross margin %
100
100
100
—
100
—
Operating margin %
421.02
6.07 M
3 476.29
—
8 930.27
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
415.39
6.07 M
3 385.71
—
8 123.68
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.66
16.67
8.96
8.72
20.84
78.33
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0
0.01
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
4.32
4.13
130.28
4.02
3.83
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
12.94
8.73
499.72
17.78
57.3
Net current asset value per share
—
13.08
8.98
507.81
17.98
58.13
Tangible book value per share
—
12.97
8.54
471.5
17.67
57.09
Working capital per share
—
12.3
7.97
449.58
17.12
55.17
Book value per share
—
12.98
8.54
471.5
17.67
57.09
Notizie
Netflix, Dell among market cap stock movers on Friday
Why Is Neurogene Stock Skyrocketing Friday? - Neurogene (NASDAQ:NGNE)
Le azioni Neurogene balzano del 30% dopo lo status di terapia innovativa FDA
Neurogene stock surges 30% on FDA breakthrough therapy status
FDA grants breakthrough therapy status to Neurogene’s Rett drug
Stifel conferma il rating Buy sulle azioni Neurogene, cita margine di sicurezza
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin
Neurogene doses multiple patients in Rett syndrome gene therapy trial
Citizens conferma il rating Market Outperform per le azioni di Taysha Gene Therapies
Citizens reiterates Market Outperform rating on Taysha Gene Therapies stock
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Neurogene: From Speculation To Execution With NGN-401 (NASDAQ:NGNE)